Buay, Rica Jane .

HRN: 05-34-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2026
CO-AMOXICLAV 625MG (TAB)
08/13/2026
08/19/2026
ORAL
625mg
BID
S/P NSVD + RMLE
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: